Founded in 2015, Jiangsu Trautec Medical Technology Co., Ltd. is dedicated to the development and production of recombinant collagen-based biomaterials with the mission of developing recombinant collagen biomaterials.
The accumulated investment of the company is nearly 100 million yuan, and the production plant located in Changzhou, Jiangsu reaches 10,000 square meters. The company has an excellent technical team with independent intellectual property rights in the development of recombinant collagen. We will continue to expand the application of recombinant human-derived collagen products in high-end fields such as medicine, medical regeneration and medical aesthetics, and occupy the forefront of the industry, aiming to build a global leading company in recombinant human-derived collagen products!More
2022-07-01Trautec's Recombinant Type XVII Collagen Wins Personal Care Industry Ringier Technology Innovation Award
Recombinant human collagen / patent No：ZL 2013 1 0033299.6
Chief ScientistProf. Jiang XiaAssociate professor of the Chinese University of Hong Kong
Prof. Xia, is the associate professor in chemistry (tenured) and life science department, he received his PhD in Stanford University and then conducted a postdoctoral research in California Institute of Technology. His engaged in the research on biochemistry, proteomic and enzyme engineering, focused on artificial organelles and polypeptide drugs and their application in synthetic biology and biomedicine, respectively. Prof. Xia’s research was strongly supported by the Research Grants Council, the Innovation and Technology Commission and the Food and Health Bureau in Hong Kong, financed by large listed pharmaceutical company.
Chief technology officerDr. Lei ZhangTechnic Director of Unicollagen
Dr. Zhang was PhD and Postdoc researcher on biochemistry in the University of Nottingham. In 2009, he has been awarded the title of provincial innovative and entrepreneurial talent by Jiangsu High-level innovative and entrepreneurial talent recruitment programme, selected to the Talent honorary project in Wujin of Changzhou. In 2018, he has obtained the title of the Leading Innovative Talent through the Longcheng Elite programme in Changzhou, and the provincial title of innovative and entrepreneurial Doctor through Jiangsu High-level innovative and entrepreneurial talent recruitment programme...